75 Results for "

Radioligand

" in MedChemExpress (MCE) Product Catalog:
Products (75)

75 Results for "Radioligand" in MCE Product Catalog:

8
8 Publications Verification
Cat. No.: HY-10569
CAS No.: 854107-55-4
Purity:  99.78%
Synonyms: ACT-128800
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

Ponesimod (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod can protect against lymphocyte-mediated tissue inflammation .
loading...
    loading...
8
8 Publications Verification
Cat. No.: HY-14121
CAS No.: 264622-58-4
Purity:  98.31%
MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122537A
CAS No.: 68377-92-4
Purity:  99.93%
Research Areas:  

Cardiovascular Disease

Arotinolol is a nonselective α/β-adrenergic receptor blocker and a vasodilating β-blocker . Arotinolol also shows potency for inhibiting the binding of the radioligand 125I-ICYP to 5HT1B-serotonergic receptor sites . Arotinolol is an antihypertensive agent for the treatment of a variety of cardiovascular pathologies as well as non-cardiovascular diseases .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122203
CAS No.: 361979-40-0
Purity:  98.88%
Research Areas:  

Neurological Disease

PCS1055 dihydrochloride is a potent, selective and competitive muscarinic M4 receptor antagonist with an IC50 of 18.1 nM and a Kd of 5.72 nM. PCS1055 dihydrochloride inhibits radioligand [ 3H]-NMS binding to the M4 receptor with a Ki of 6.5 nM. PCS1055 dihydrochloride exhibits >100-fold selectivity over M1-, M3-, and M5-receptors and 30-fold selectivity at the M2 receptor. PCS1055 dihydrochloride is also a potent AChE inhibitor with IC50 s of 22 nM and 120 nM for electric eel and human AChE, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122203A
CAS No.: 357173-55-8
Purity:  98.02%
Research Areas:  

Neurological Disease

PCS1055 is a selective and competitive antagonist for muscarinic M4 receptor with an IC50 of 18.1 nM and a Kd of 5.72 nM. PCS1055 inhibits radioligand [ 3H]-NMS binding to the M4 receptor with a Ki of 6.5 nM. PCS1055 is also an inhibitor for AChE with IC50 of 22 nM and 120 nM for electric eel and human AChE, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122537
CAS No.: 68377-91-3
Research Areas:  

Cardiovascular Disease

Arotinolol hydrochloride is a nonselective α/β-adrenergic receptor blocker and a vasodilating β-blocker . Arotinolol hydrochloride also shows potency for inhibiting the binding of the radioligand 125I-ICYP to 5HT1B-serotonergic receptor sites . Arotinolol hydrochloride is an antihypertensive agent for the treatment of a variety of cardiovascular pathologies as well as non-cardiovascular diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1486
CAS No.: 6452-73-9
Synonyms: Ba 39089
Target:  

Adrenergic Receptor

Research Areas:  

Cardiovascular Disease

Oxprenolol hydrochloride (Ba 39089) is an orally bioavailable β-adrenergic receptor (β-AR) antagonist with a Ki of 7.10 nM in a radioligand binding assay using rat heart muscle .
loading...
    loading...
Cat. No.: HY-P1096
CAS No.: 130408-77-4
Research Areas:  

Metabolic Disease

A71623, a CCK-4-based peptide, is a potent and highly selective CCK-A full agonist. The IC50s for A-71623 are 3.7 nM in guinea pig pancreas (CCK-A) and 4500 nM in cerebral cortex (CCK-B) in radioligand binding assays, respectively .
loading...
    loading...
Cat. No.: HY-100982
CAS No.: 24587-49-3
Purity:  ≥98.0%
Synonyms: trans-4-Hydroxycrotonic acid; trans-γ-Hydroxycrotonic acid; T‐HCA
(E)-4-Hydroxycrotonic acid (trans-4-Hydroxycrotonic acid) is a semirigid linear analog of γ-Hydroxybutyric acid. (E)-4-Hydroxycrotonic acid can be present in the mammalian central nervous system. (E)-4-Hydroxycrotonic acid binds to high-affinity γ-Hydroxybutyric acid binding sites and displaces radioligands .
loading...
    loading...
Cat. No.: HY-141536
CAS No.: 2306049-48-7
Purity:  98.92%
Research Areas:  

Cancer

PSMA-ALB-56 is a PSMA-targeting radioligand designed by combining the glutamate-urea PSMA-binding entity and an albumin binder .
loading...
    loading...
Cat. No.: HY-133116
CAS No.: 435293-66-6
Purity:  97.04%
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease

4-Hydroxyatomoxetine is an active metabolite of Atomoxetine. 4-Hydroxyatomoxetine is metabolized by the enzyme cytochrome P450 2D6 (CYP2D6). Atomoxetine hydrochloride is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5 nM, 77 nM and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively) .
loading...
    loading...
Cat. No.: HY-141261A
CAS No.: 2245150-18-7
Research Areas:  

Cancer

Methyltetrazine-PEG4-amine hydrochloride is a linker for antibody-drug conjugates and a click chemistry reagent that can be used for the synthesis of ADCs. Methyltetrazine-PEG4-amine hydrochloride can be used to synthesize click-active albumin-binding radioligands as well as VLA-4-targeted radiopharmaceutical precursors. Methyltetrazine-PEG4-amine hydrochloride is applicable to research related to prostate cancer .
loading...
    loading...
Cat. No.: HY-12761
CAS No.: 959746-77-1
Purity:  99.84%
A-836339 is a selective CB2 receptor agonist, with Ki values of 0.4 nM and 0.8 nM in humans and rats, respectively. A-836339 exhibits multiple effects such as analgesia, gastric protection, anti-inflammation, and antioxidant activity. A-836339 produces antinociceptive and analgesic activities by activating CB2 receptors in the dorsal root ganglia and spinal cord. A-836339 can also exert gastric protective effects through anti-inflammatory mechanisms (reducing TNF-α and IL-1β) and antioxidant mechanisms (enhancing the activities of CAT and SOD, and reducing H2O2). Radioactively labeled A-836339 can serve as a CB2-specific radioligand for autoradiography and PET imaging. A-836339 can be used in research on inflammatory pain, neuropathic pain, gastric ulcers, cerebral ischemia, etc .
loading...
    loading...
Cat. No.: HY-161246
CAS No.: 2323525-19-3
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

uPSEM792 is a pharmacologically selective effector molecules (PSEM) agonist for PSAM 4-GlyR, with an affinity of Ki of 0.7 nM. uPSEM792 is a substrate for efflux transporters in brains of wild type and dual P-gp and BCRP knockout mice. uPSEM7952 is a possible lead for developing the PET radioligand for PSAM 4-GlyR .
loading...
    loading...
Cat. No.: HY-100027A
CAS No.: 127917-66-2
Purity:  99.96%
Research Areas:  

Neurological Disease

Ro 41-1049 hydrochloride is a highly selective, reversible MAO-A inhibitor. Ro 41-1049 hydrochloride effectively blocks the Quinpirole (HY-B1752)-induced increase in dopamine D2-like receptor density in the nucleus accumbens and alters the pattern of behavioral sensitization, shifting animals' responses from enhanced motor activity to immobile self-directed gaping behavior. Tritium-labeled Ro 41-1049 hydrochloride serves as a high-affinity radioligand, enabling accurate mapping of the distribution and abundance of MAO-A in the central nervous system, peripheral organs, and human brain via quantitative enzyme autoradiography. Ro 41-1049 hydrochloride can be used for basic research on depression and other related diseases .
loading...
    loading...
Cat. No.: HY-19888
CAS No.: 1001389-72-5
GSK-1482160 is an orally active and blood-brain barrier penetrant P2X7 receptor (P2X7R) negative allosteric modulator with pIC50s of 8.5 (human) and 6.5 (rat). GSK-1482160 reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity, thereby inhibiting the release of IL-1β. GSK-1482160 is an effective radioligand and can be labeled with radioactive isotopes like 11C or 18F to image P2X7R. GSK-1482160 can be used for the studies of chronic joint pain and chronic constriction injury (CCI) .
loading...
    loading...
Cat. No.: HY-141804
CAS No.: 1373887-29-6
Purity:  99.77%
Synonyms: BIBD-239
Research Areas:  

Neurological Disease

ER176 is a next generation PET radioligand for imaging 18 kDa translocator protein (TSPO), a biomarker for neuroinflammation .
loading...
    loading...
Cat. No.: HY-171806
CAS No.: 1257213-96-9
Target:  

LPL Receptor

Research Areas:  

Cancer

BMT-136088 is a LPAR1 antagonist . 11C-BMT-136088 can be used as a positron emission tomography (PET) radioligand to quantify specific binding to LPA1 in lung.
loading...
    loading...
Cat. No.: HY-B1486AS
CAS No.: 1189805-10-4
Oxprenolol-d7 is the deuterium labeled Oxprenolol. Oxprenolol (Ba 39089 free base) is an orally bioavailable β-adrenergic receptor (β-AR) antagonist with a Ki of 7.10 nM in a radioligand binding assay using rat heart muscle .
loading...
    loading...
Cat. No.: HY-148353
CAS No.: 1527474-15-2
Target:  

LRRK2

Research Areas:  

Neurological Disease

PF-06455943 is a leucine rich repeat kinase 2 (LRRK2) inhibitor with IC50 value of 3 nM. PF-06455943 also is a PET radioligand. PF-06455943 can be used for the research of ADME/neuro PK characterization and Parkinson disease (PD) .
loading...
    loading...